Particularly, FUS application combined with intranasal delivery may be helpful in achieving infusion of neurotrophins, like NGF and BDNF, into specific damaged areas of the brain, of foremost clinical relevance in AD therapy. This evidence concerns the gene NGF and Alzheimer disease.